Joint Procurement for Ibuprofen   3

Background
The Department of Veterans Affairs (VA) is issuing an amendment to extend the offer due date for a joint procurement for Ibuprofen. The revised offer due date is March 02, 2022 at 10am CST. The VA National Acquisition Center, Pharmaceutical Division, is responsible for acquiring pharmaceutical requirements through the Pharmaceutical Prime Vendor Programs (PPV) and the Pharmaceutical Repackaging Program (PRP). The purpose of this solicitation is to establish a supply source that will provide drugs listed in the schedule for purchase through the PPV Programs. The objective is to ensure availability and consistency of product for nationwide usage and to obtain volume-based, committed-use pricing.

Work Details
The contract involves the procurement of Ibuprofen tablets in various strengths and package sizes. The contract requires offerors to submit prices for the base year and all four one-year options for all line items within each group. Offered prices must include a 0.5% Cost Recovery Fee as outlined in the Scope of Contract.

The estimated annual usage quantities are provided for each strength and bottle size/tablet count listed, but there is no guarantee that these quantities will be purchased under this contract. Large volume containers are required for bulk submissions, defined as buckets, pails, or drums containing 10,000 or more tablets. The minimum package size for bulk submissions is 1,000 count bottles.

Additionally, the contractor must provide products with at least 18 months of dating prior to product expiration on the date of shipment from the contract holder to the Pharmaceutical Repackager.

Period of Performance
The period of performance for this contract is not explicitly stated in the provided information.

Place of Performance
The place of performance includes delivery to VA PPV for Group 1 - line items 1 – 6 and delivery to the Pharmaceutical Repackager for Group 2 - line items 1-3.